Efficacy and Safety of Mirvetuximab Soravtansine in Patients with Platinum-Resistant Ovarian Cancer with High Folate Receptor Alpha Expression: Results from the SORAYA Study (LBA 4)
Ursula A. Matulonis, Domenica Lorusso, Ana Oaknin, Sandro Pignata, Hannelore Denys, Nicoletta Colombo, Toon Van Gorp, Jason Konner, Margarita Romeo Marin, Philipp Harter, Conleth G. Murphy, Jiuzhou Wang, Elizabeth Noble, Brooke Esteves, Michael Method, Robert E. Coleman
Topics & Concepts
MedicineInternal medicineClinical endpointTolerabilityOvarian cancerBevacizumabPhases of clinical researchOncologyGastroenterologyAdverse effectSurgeryCancerToxicityClinical trialChemotherapyOvarian cancer diagnosis and treatmentPARP inhibition in cancer therapyRenal cell carcinoma treatment